| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,625 |
11,171 |
$452K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,080 |
6,453 |
$312K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
8,875 |
6,820 |
$52K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,789 |
3,003 |
$43K |
| 99406 |
|
6,303 |
4,939 |
$40K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
631 |
569 |
$34K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
187 |
174 |
$13K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,924 |
1,630 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
414 |
361 |
$7K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
106 |
101 |
$7K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,001 |
869 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
215 |
186 |
$5K |
| 90756 |
|
389 |
335 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
456 |
324 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
49 |
40 |
$3K |
| 90674 |
|
180 |
139 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
253 |
220 |
$2K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
331 |
279 |
$2K |
| 99401 |
|
129 |
102 |
$1K |
| 90661 |
|
78 |
77 |
$1K |
| 3008F |
|
229 |
191 |
$1K |
| 99385 |
|
15 |
14 |
$1K |
| 81003 |
|
869 |
724 |
$843.07 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,279 |
1,930 |
$754.67 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
23 |
17 |
$651.85 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
25 |
24 |
$250.64 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
212 |
177 |
$141.98 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
232 |
187 |
$77.87 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
47 |
40 |
$35.16 |
| G0008 |
Administration of influenza virus vaccine |
286 |
242 |
$5.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
29 |
24 |
$5.74 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
4,494 |
3,456 |
$0.02 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
3,420 |
2,715 |
$0.02 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
22,059 |
16,424 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,854 |
1,561 |
$0.00 |
| 1159F |
|
655 |
556 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
9,179 |
7,085 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
349 |
287 |
$0.00 |
| 4004F |
|
1,752 |
1,445 |
$0.00 |
| 1160F |
|
255 |
228 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
230 |
205 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
20 |
16 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
4,757 |
3,844 |
$0.00 |
| 1125F |
|
88 |
80 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
9,257 |
7,089 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
2,045 |
1,716 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
275 |
213 |
$0.00 |
| 1036F |
|
3,815 |
3,030 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
336 |
303 |
$0.00 |
| 1126F |
|
640 |
553 |
$0.00 |
| 91301 |
|
18 |
13 |
$0.00 |
| 1170F |
|
42 |
39 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
47 |
42 |
$0.00 |